For the year ending 2025-12-31, CPHI made $4,144,268 in revenue. -$2,924,552 in net income. Net profit margin of -70.57%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenue | 4,144,268 | |||
| Cost of revenue | 4,276,218 | |||
| Gross loss | -131,950 | |||
| Selling expenses | 375,786 | |||
| General and administrative expenses | 2,451,459 | |||
| Research and development expenses | 280,901 | |||
| Credit (gains) losses | -1,018 | |||
| Total operating expenses | 3,107,128 | |||
| Loss from operations | -3,239,078 | |||
| Research and development subsidy | 151,556 | |||
| Interest income | 2,003 | |||
| Interest expense | 102,037 | |||
| Net other income (expense) | 51,522 | |||
| Loss before income taxes | -3,187,556 | |||
| Net loss | -3,187,556 | |||
| Other comprehensive income (loss) - foreign currency translation adjustment | 263,004 | |||
| Comprehensive loss | -2,924,552 | |||
| Basic EPS | -0.74 | |||
| Diluted EPS | -0.74 | |||
| Basic Average Shares | 4,291,427 | |||
CHINA PHARMA HOLDINGS, INC. (CPHI)
CHINA PHARMA HOLDINGS, INC. (CPHI)